Consistent with the concentrative, antiport mechanism of SLC35-nucleotide family transporters [96], tumor models with high levels of SLC35F2, such as the PC3 prostate cancer cell line [5], are able to accumulate high intratumoral levels of YM155. This evidence concerns the gene SLC35F2 and neoplasm.